These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21262777)
21. A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network. Sanz-Pamplona R; García-García J; Franco S; Messeguer X; Driouch K; Oliva B; Sierra A Mol Biosyst; 2012 Aug; 8(8):2085-96. PubMed ID: 22710377 [TBL] [Abstract][Full Text] [Related]
22. Biochemical picture of bone metabolism in breast cancer patients with bone metastases. Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881 [TBL] [Abstract][Full Text] [Related]
23. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity. Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050 [TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer. Jeong YJ; Oh HK; Park SH; Bong JG Molecules; 2018 Jan; 23(1):. PubMed ID: 29315254 [TBL] [Abstract][Full Text] [Related]
25. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis. Witzel I; Schröder C; Müller V; Zander H; Tachezy M; Ihnen M; Jänicke F; Milde-Langosch K Oncology; 2012; 82(6):305-12. PubMed ID: 22555284 [TBL] [Abstract][Full Text] [Related]
26. Gold nanoprobe-based method for sensing activated leukocyte cell adhesion molecule (ALCAM) gene expression, as a breast cancer biomarker. Eskandari L; Akbarzadeh A; Zarghami N; Rahmati-Yamchi M Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):277-282. PubMed ID: 26923994 [TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Sawhney M; Matta A; Macha MA; Kaur J; DattaGupta S; Shukla NK; Ralhan R Int J Cancer; 2009 May; 124(9):2098-105. PubMed ID: 19142865 [TBL] [Abstract][Full Text] [Related]
28. Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis. Davies SR; Dent C; Watkins G; King JA; Mokbel K; Jiang WG Oncol Rep; 2008 Feb; 19(2):555-61. PubMed ID: 18202807 [TBL] [Abstract][Full Text] [Related]
29. Novel role for ALCAM in lymphatic network formation and function. Iolyeva M; Karaman S; Willrodt AH; Weingartner S; Vigl B; Halin C FASEB J; 2013 Mar; 27(3):978-90. PubMed ID: 23169771 [TBL] [Abstract][Full Text] [Related]
30. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422 [TBL] [Abstract][Full Text] [Related]
31. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. Ihnen M; Kress K; Kersten JF; Kilic E; Choschzick M; Zander H; Müller V; Mahner S; Jänicke F; Woelber L; Milde-Langosch K BMC Cancer; 2012 Apr; 12():140. PubMed ID: 22475274 [TBL] [Abstract][Full Text] [Related]
32. Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells. Kanderová V; Hrusák O; Kalina T Exp Hematol; 2010 Aug; 38(8):653-660.e1. PubMed ID: 20380867 [TBL] [Abstract][Full Text] [Related]
34. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116 [TBL] [Abstract][Full Text] [Related]
35. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. Park D; Kåresen R; Axcrona U; Noren T; Sauer T APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851 [TBL] [Abstract][Full Text] [Related]
36. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012 [TBL] [Abstract][Full Text] [Related]
37. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases. Mihai R; Stevens J; McKinney C; Ibrahim NB Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154 [TBL] [Abstract][Full Text] [Related]
38. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome. Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927 [TBL] [Abstract][Full Text] [Related]
40. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. Boelens MC; van den Berg A; Vogelzang I; Wesseling J; Postma DS; Timens W; Groen HJ J Clin Pathol; 2007 Jun; 60(6):608-14. PubMed ID: 16489176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]